Analysts Set Planet Labs PBC (NYSE:PL) Target Price at $35.11

Planet Labs PBC (NYSE:PLGet Free Report) has been given a consensus recommendation of “Hold” by the twelve brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $35.2750.

Several research analysts have commented on the stock. Citigroup upped their price objective on shares of Planet Labs PBC from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday, April 2nd. Morgan Stanley upped their price objective on shares of Planet Labs PBC from $26.00 to $35.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 25th. The Goldman Sachs Group restated a “neutral” rating and issued a $22.00 price objective on shares of Planet Labs PBC in a report on Thursday. Cantor Fitzgerald increased their price target on shares of Planet Labs PBC from $20.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, March 20th. Finally, Wedbush reiterated an “outperform” rating and issued a $50.00 price target on shares of Planet Labs PBC in a research note on Friday, June 5th.

Get Our Latest Stock Report on PL

Planet Labs PBC Stock Down 8.8%

Shares of NYSE PL opened at $31.16 on Wednesday. The company has a current ratio of 2.81, a quick ratio of 2.78 and a debt-to-equity ratio of 1.01. Planet Labs PBC has a 12 month low of $4.90 and a 12 month high of $51.76. The firm has a market capitalization of $11.11 billion, a PE ratio of -27.34 and a beta of 1.99. The firm has a fifty day simple moving average of $38.99 and a two-hundred day simple moving average of $28.35.

Planet Labs PBC (NYSE:PLGet Free Report) last issued its quarterly earnings data on Thursday, June 4th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. Planet Labs PBC had a negative net margin of 111.17% and a negative return on equity of 105.29%. The business had revenue of $94.15 million during the quarter, compared to analyst estimates of $90.39 million. The firm’s revenue for the quarter was up 42.1% compared to the same quarter last year. Equities analysts expect that Planet Labs PBC will post -0.81 earnings per share for the current year.

Trending Headlines about Planet Labs PBC

Here are the key news stories impacting Planet Labs PBC this week:

Insider Activity

In related news, insider Robert H. Schingler sold 73,683 shares of the stock in a transaction dated Monday, April 6th. The shares were sold at an average price of $35.07, for a total value of $2,584,062.81. Following the completion of the transaction, the insider directly owned 256,488 shares in the company, valued at $8,995,034.16. This trade represents a 22.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ashley F. Johnson sold 200,000 shares of the stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $35.10, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief financial officer owned 1,895,162 shares of the company’s stock, valued at approximately $66,520,186.20. The trade was a 9.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 16.42% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Western Wealth Management LLC bought a new position in shares of Planet Labs PBC in the 1st quarter worth about $28,000. Oddo BHF Asset Management Sas bought a new position in shares of Planet Labs PBC in the 1st quarter worth about $5,472,000. Amundi increased its stake in shares of Planet Labs PBC by 30.7% in the 1st quarter. Amundi now owns 20,280 shares of the company’s stock worth $567,000 after acquiring an additional 4,765 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Planet Labs PBC by 243.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 2,965 shares of the company’s stock worth $83,000 after acquiring an additional 2,102 shares in the last quarter. Finally, California State Teachers Retirement System increased its stake in shares of Planet Labs PBC by 22.6% in the 1st quarter. California State Teachers Retirement System now owns 285,952 shares of the company’s stock worth $7,992,000 after acquiring an additional 52,806 shares in the last quarter. 41.71% of the stock is currently owned by institutional investors.

About Planet Labs PBC

(Get Free Report)

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.

Read More

Analyst Recommendations for Planet Labs PBC (NYSE:PL)

Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.